Key Highlights
• Fortrea Holdings (NASDAQ: FTRE) appoints Jason Knoblauch as CFO, effective July 6, 2026, taking over from Jill McConnell.
• Knoblauch’s compensation features a $570,000 annual base salary and an 85% target bonus.
• The company will provide a $1.25 million cash inducement award, with $500,000 paid at signing and $750,000 after one year.
• Equity incentives include restricted stock units valued at $2.3 million and performance-based awards worth $1.7 million.
Fortrea Holdings (NASDAQ: FTRE) has announced a key leadership change, naming Jason Knoblauch as its incoming Chief Financial Officer. The transition becomes official on July 6, 2026, as Jill McConnell departs the CFO role but continues with the company during a brief handover period.
CFO Transition Timeline
Knoblauch will officially step into the CFO position on July 6, 2026, following McConnell’s exit. Fortrea has clarified that McConnell’s departure is not connected to any concerns over financial reporting or internal controls. The company released details of the leadership shift in a June 26, 2026, press statement.
New CFO’s Professional Background
Knoblauch arrives with extensive experience in finance and the life sciences sector. Before joining Fortrea, he served as Executive Vice President and CFO at Clario, a company specializing in digital endpoint data solutions, from August 2023 through June 2026. His previous roles include CFO at Curia and senior finance leadership positions at Pharmaceutical Product Development (PPD).
Compensation Structure Details
Knoblauch’s compensation package includes an annual base salary of $570,000, along with a target bonus set at 85% of that amount. Additionally, Fortrea will provide a $1.25 million cash inducement award, structured as $500,000 payable upon hiring and $750,000 after one year of service.
Equity Incentives Designed for Performance Alignment
Fortrea has structured Knoblauch’s equity awards to emphasize long-term performance, with 42.5% tied to performance-based stock units (PSUs). The remaining 57.5% consists of time-based restricted stock units (RSUs).
Long-Term Incentive Framework
Beginning in 2028, future equity grants will follow a balanced approach, with 50% allocated to RSUs and 50% to PSUs. The initial annual grant under this plan will hold an aggregate fair market value of $2 million. Vesting conditions for PSUs include a three-year performance period, with a maximum cap of 400,000 shares.
Severance and Indemnification Provisions
Knoblauch is covered under Fortrea’s Master Senior Executive Severance Plan, which outlines severance eligibility. The company has also agreed to indemnify him for certain legal expenses related to claims arising from his prior employment. Equity awards are subject to double-trigger vesting in the event of a change in corporate control.
Board Approval and Regulatory Compliance
The appointment adheres to Nasdaq Listing Rule 5635, which regulates inducement awards. Fortrea’s board of directors approved the full compensation package, including both cash and equity components, to ensure Knoblauch’s incentives are closely aligned with creating shareholder value. This approach reflects the company’s focus on fostering long-term growth in the competitive clinical research and drug development services sector.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.



_11_17_2026_20_37_58_946960.jpg)


Please wait processing your request...